Stanford University
Showing 5,201-5,250 of 34,489 Results
-
Yueh-hsiu Chien
Professor of Microbiology & Immunology
Current Research and Scholarly InterestsContribution of T cells to immunocompetence and autoimmunity; how the immune system clears infection, avoids autoimmunity and how infection impacts on the development of immune responses.
-
Nymisha Chilukuri, MD
Clinical Assistant Professor, Pediatrics - General Pediatrics
Current Research and Scholarly InterestsMy research interests are to use clinical informatics to improve access to equitable care for children in under-served communities. My main areas of research interest currently include optimizing clinical informatics solutions for those with non-English preferred languages and improving interoperability between health systems, public health and community partners for pediatric patients and families.
-
Alexander Chin, MD, MBA
Clinical Associate Professor, Radiation Oncology - Radiation Therapy
BioAlexander Chin, MD, MBA, is a radiation oncologist with Stanford Medicine Cancer Center and a clinical associate professor in the Department of Radiation Oncology with the Stanford School of Medicine. He also serves as Executive Director of Market Development, Cancer Services for Stanford Health Care, acting as a liaison between faculty leadership and hospital administration, to advance Stanford Medicine’s mission of providing compassionate leading-edge care to the communities that we serve.
Dr. Chin is committed to ensuring the delivery of care of the highest quality and value. He provides clinical expertise in diagnosing and treating the full range of cancers, including those of the lung, breast, and central nervous system. In addition, he serves on national leadership teams formed to advance the practice of cancer care. Dr. Chin is currently a member of the Payment Reform Task Force for the American Society of Clinical Oncology and has previously served on their Clinical Practice Committee and as a health policy fellow. He was one of just two oncologists in the US selected to participate in a year-long program on policy leadership.
He currently serves on the Stanford Cancer Network Quality Committee. This team develops and implements our care delivery standards, strategies, and metrics to ensure consistently excellent cancer care from all Stanford Health Care providers in all locations.
Dr. Chin has conducted extensive research and published his findings in numerous peer-reviewed journals. Topics range from novel oncology payment models to the use of new imaging parameters in lung cancer. His scholarship appears in Cancer, JCO Oncology Practice, Clinical Lung Cancer, International Journal of Radiation Oncology, Biology, Physics, and elsewhere.
He has made presentations on stereotactic body radiotherapy (SBRT) and other treatment advances at meetings of the Radiological Society of North America and American Society for Radiation Oncology. He also has addressed these topics as an invited lecturer in training sessions for oncology residents.
He has won numerous awards, including recognition for his research from the Radiological Society of North America. He also has earned honors from the American Society of Clinical Oncology and from his alma maters: the Perelman School of Medicine at the University of Pennsylvania as well as Wharton and Yale.
Dr. Chin earned a Bachelor of Science degree in molecular biophysics and biochemistry from Yale University. He earned his medical degree from Perelman School of Medicine at the University of Pennsylvania, and his MBA at the Wharton School. He completed his residency in Radiation Oncology at Stanford Health Care.
He is a member of the Radiological Society of North America, American Society for Radiation Oncology, and American Society for Clinical Oncology. -
Andrew Chin, DO, MS, MPH
Clinical Assistant Professor, Medicine
BioDr. Andrew Chin is a Clinical Assistant Professor in the Division of Hospital Medicine at Stanford University School of Medicine and works as a hospitalist at Stanford Health Care. He attended medical school at Midwestern University in Glendale, Arizona and completed his internal medicine residency at University Hospitals of Cleveland in Cleveland, Ohio.
-
Edward Paul Chin
Safety Sys Engineerin Director, Accelerator
Current Role at StanfordMy role at SLAC is to support the mission of the lab by integrating a fully functional safety system which includes the Personnel Protection System, Hutch Protection System, Beam Containment System, Non-Ionizing Radiation Protection System, and the Oxygen Deficiency Monitoring System. I ensure the division is adequately staffed to design, build, test, and support the safety systems as required by the program.
-
Natalie Maureen Chin
Clinical Instructor (Affiliated), School of Medicine - Senior Associate Dean for Medical Student Education
BioPediatric General Surgery APP with Lucile Packard Children's Hospital. Education includes Master of Science of Physician Assistant Studies from Midwestern University Class of 2021, B.S. in Physiological Science from UCLA Class of 2016.
-
Ryan Chin
Managing Director, Sustainable Mobility Center, Precourt Institute for Energy
Current Role at StanfordManaging Director, Sustainable Mobility Center (SMC), Stanford Doerr School of Sustainability, Precourt Institute of Energy
-
Justine Chinn
Resident in Surgery
BioJustine Chinn is a general surgery resident at Stanford University. She completed her medical degree from University of California Irvine in 2021. She is currently a Stanford AHRQ Health Policy fellow and performing outcomes research with the Minimally Invasive/Bariatric Surgery team.
-
Sahil Chinoy
Assistant Professor of Political Science
BioSahil Chinoy is an assistant professor of political science studying the contemporary and 20th-century political economy of the United States. Previously, he was a graphics editor at The New York Times.
-
Albert Sean Chiou, MD, MBA
Clinical Professor, Dermatology
Current Research and Scholarly InterestsI am a clinical researcher interested in evaluating promising new diagnostic paradigms and treatments for serious or poorly treated, chronic skin conditions. My research currently includes:
Therapeutics:
- Treatments for atopic dermatitis and other inflammatory skin conditions
- Treatments for itch from epidermolysis bullosa
- Treatments for chronic wounds for patients with recessive dystrophic epidermolysis bullosa (In collaboration with Dr. Jean Tang and Dr. Peter Marinkovich)
Diagnostics:
- Artificial intelligence approaches for melanoma and skin cancer early detection
- Imaging mass spectrometry for skin cancer margin analysis and diagnosis
I collaborate with other faculty within the Stanford Skin Innovation and Interventional Research Group (SIIRG) to conduct investigator initiated and sponsored clinical trials seeking to improve care for important dermatologic diseases
Please learn more about our work at: https://siirg.stanford.edu/ -
Gheorghe Chistol
Assistant Professor of Chemical and Systems Biology
Current Research and Scholarly InterestsResearch in my laboratory is aimed at understanding how eukaryotes replicate their DNA despite numerous challenges (collectively known as replication stress), and more generally – how eukaryotic cells safeguard genome integrity. Specifically, we are investigating: (i) mechanisms that regulate the activity of the replicative helicase during replication stress, (ii) mechanisms that control the inheritance of epigenetic information during replication, and (iii) mechanisms of ubiquitin-mediated regulation of genome maintenance. We utilize single-molecule microscopy to directly image fluorescently-labeled replication factors and track them in real time in Xenopus egg extracts. I developed this system as a postdoctoral fellow, and used it to monitor how the eukaryotic replicative helicase copes with DNA damage. We plan to further extend the capabilities of this platform to directly visualize other essential replication factors, nucleosomes, and regulatory post-translational modifications like ubiquitin chains. By elucidating molecular mechanisms responsible for maintaining genome stability, we aim to better understand the link between genome instability and cancer, and how these mechanisms can be harnessed to improve disease treatment.
